Schedule 13G ownership disclosure

Forte Biosciences Inc

Common Stock · CUSIP: 34962G208

Event date: 2025-06-30

Filing-level shares
1,618,649
Percent of class
13.3%
  • Alger Associates, Inc.

    Shares: 1,618,649 · Class: 13.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-108951
Form type
SCHEDULE 13G/A
Filer
ALGER ASSOCIATES INC
CIK
CIK 1000264
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub